Industry Developments

The US and Mexico are in discussions about providing cross-border healthcare for Mexican immigrants. The outline of plan envisages migrants having access to health services regardless... 2007-06-19

The US FDA has approved Letairis (ambrisentan0, a new drug from US-based drugmaker

Johnson & Johnson (J&J) is hopeful that the purchase of fellow US healthcare giant Pfizer's OTC division in 2006, for US$16.6bn will help drive sales in the coming years.... 2007-06-11

The CEO of US-based biotech major Genentech has defended his firm's pricing policies in a recent interview with the Wall Street Journal. Pointing out that the company invested US$1.8bn... 2007-06-08

Dorsay Monange (DM) Farmacêutica, one of Brazil's leading over-the-counter (OTC) producers, is reportedly being sold to recently formed consumer products holding Hypermarcas. The... 2007-06-08

Biotech major Amgen has acquired two US-based drugmakers specialising in the treatments for renal disease and diabetes. The deals come at a difficult time for the company as it... 2007-06-07

US drugmaker Wyeth 's first-in-class cancer drug Torisel (temsirolimus) has been approved by the US FDA. The drug is indicated for renal cell carcinoma (RCC) and data has shown that... 2007-06-06

The Argentine pharmaceutical market was valued at US$2.4bn in 2006 and continues to expand steadily. Sales are expected to reach US$3.0bn in 2011. While the market has recovered from... 2007-06-06

Indian drugmaker Ranbaxy has acquired the US rights for 13 dermatology products from drug major Bristol-Myers Squibb (BMS). The drugs, which have all been on the market for over... 2007-06-04

A prominent Mexican politician has called for reforms of the General Health Law to limit prescription dispensing to the quantities indicated in prescriptions, reduce counterfeiting... 2007-06-04